Clinical Study
The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes
Table 1
Demographic features, indication for EGD, and EGD findings of patients with intestinal metaplasia.
| | | () |
| | Sex | | | Male | 227 (40.5%) | | Female | 333 (59.5%) | | Age (years) | 57.0 ± 15.3 (17–98) | | Age groups | | | <31 | 29 (5.2%) | | 31–40 | 56 (10%) | | 41–50 | 115 (18.8%) | | 51–60 | 144 (25.7%) | | 61–70 | 113 (20.2%) | | 71–80 | 87 (15.5%) | | >80 | 26 (4.6%) | | Indication for EGD | | | Dyspepsia | 231 (41.2%). | | Abdominal pain | 145 (25.9%) | | GERD | 75 (13.4%) | | Cancer screening | 29 (5.2%) | | Others | 80 (14.3%) | | EGD findings | | | Gastritis (nonerosive, erosive, atrophic, etc) | 378 (67.5%) | | Gastric ulcer | 34 (6.1%) | | Gastric cancer | 22 (3.9%) | | Others | 126 (22.5%) |
|
|
GERD: gastroesophageal reflux disease; EGD: esophagogastroduodenoscopy.
|